Top Markets
Coin of the day
ABL Diagnostics Société anonyme ABL Diagnostics Société anonyme

ABL Diagnostics Société anonyme

ABLD
Kedudukan dalam Saham #26286
ABL Diagnostics Société anonyme provides proprietary molecular biology assays... ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Harga Saham
$2.61
Modal Pasaran
$41.93M
Perubahan (1 hari)
-6.78%
Perubahan (1 tahun)
-50.24%
Negara
FR
Perdagangan ABL Diagnostics Société anonyme (ABLD)

Kategori

Pendapatan untuk ABL Diagnostics Société anonyme (ABLD)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini ABL Diagnostics Société anonyme, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi ABL Diagnostics Société anonyme dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$2.04B -
US
$222.34M -
AU
$-259.89M -
US
$295.53M -
US
- -
US